EP3139937A4 - Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis - Google Patents

Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis Download PDF

Info

Publication number
EP3139937A4
EP3139937A4 EP15789993.1A EP15789993A EP3139937A4 EP 3139937 A4 EP3139937 A4 EP 3139937A4 EP 15789993 A EP15789993 A EP 15789993A EP 3139937 A4 EP3139937 A4 EP 3139937A4
Authority
EP
European Patent Office
Prior art keywords
angiogenesis
induction
modulation
methods
sustained release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15789993.1A
Other languages
German (de)
French (fr)
Other versions
EP3139937A1 (en
Inventor
Peter S. MCFETRIDGE
Marc C. MOORE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida Research Foundation Inc filed Critical University of Florida Research Foundation Inc
Publication of EP3139937A1 publication Critical patent/EP3139937A1/en
Publication of EP3139937A4 publication Critical patent/EP3139937A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP15789993.1A 2014-05-08 2015-05-07 Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis Withdrawn EP3139937A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461990256P 2014-05-08 2014-05-08
PCT/US2015/029666 WO2015171880A1 (en) 2014-05-08 2015-05-07 Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis

Publications (2)

Publication Number Publication Date
EP3139937A1 EP3139937A1 (en) 2017-03-15
EP3139937A4 true EP3139937A4 (en) 2017-12-27

Family

ID=54392991

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15789993.1A Withdrawn EP3139937A4 (en) 2014-05-08 2015-05-07 Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis

Country Status (6)

Country Link
EP (1) EP3139937A4 (en)
JP (1) JP2017520517A (en)
KR (1) KR20160147055A (en)
AU (1) AU2015255907A1 (en)
CA (1) CA2948348A1 (en)
WO (1) WO2015171880A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081817A1 (en) * 2018-10-17 2020-04-23 University Of Florida Research Foundation Magnetically responsive composite microparticles for triggered delivery of biologically active agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218065A2 (en) * 1985-08-30 1987-04-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Reconstituted basement membrane complex with biological activity
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US20130195992A1 (en) * 2005-09-27 2013-08-01 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
JP2770926B2 (en) * 1985-12-17 1998-07-02 サイナーゲン インコーポレーテッド Human placental angiogenesis inducer capable of promoting capillary endothelial cell protease synthesis, DNA synthesis and migration
JPS63152322A (en) * 1986-09-30 1988-06-24 Ichimaru Pharcos Co Ltd Solution containing fibronectin derived from placenta tissue
JPH0931100A (en) * 1995-07-24 1997-02-04 Nippon Ham Kk Denaturated collagen and its production
US7775965B2 (en) * 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
CN104873956B (en) * 2005-09-27 2019-04-23 组织技术公司 The composition and its application method of amniotic membrane preparations and purifying
EP2663637B1 (en) * 2011-01-10 2017-09-27 Noveome Biotherapeutics, Inc. Accs for use in accelerating the healing of connective tissue injuries

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218065A2 (en) * 1985-08-30 1987-04-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Reconstituted basement membrane complex with biological activity
US20130195992A1 (en) * 2005-09-27 2013-08-01 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery

Also Published As

Publication number Publication date
JP2017520517A (en) 2017-07-27
KR20160147055A (en) 2016-12-21
EP3139937A1 (en) 2017-03-15
CA2948348A1 (en) 2015-11-12
WO2015171880A1 (en) 2015-11-12
AU2015255907A1 (en) 2016-12-01

Similar Documents

Publication Publication Date Title
IL273058A (en) Compositions and methods for modulating pkk expression
AU2015370664B2 (en) Immune modulation
EP3139957A4 (en) Compositions and methods for growth factor modulation
AU2015370664A1 (en) Immune modulation
EP3218483A4 (en) Compounds and methods for the modulation of proteins
EP3152319A4 (en) Methods and compositions for nuclease design
EP3096759A4 (en) Modified release formulations of pridopidine
EP3092763A4 (en) Combined amplitude-time modulation and phase modulation
EP3154561A4 (en) Modulation of complement activity
EP3137596A4 (en) Compositions and methods for modulating complement factor b expression
EP3139943A4 (en) Combinations of nmdar modulating compounds
EP3131723A4 (en) Modulation of thixotropic properties of cementitious materials
EP3307782A4 (en) Methods and antibodies for modulation of immunoresponse
EP3226859A4 (en) Compositions and methods of modulating s-nitrosylation
EP3107567A4 (en) Methods of modulating an immune response
EP3099443A4 (en) Induction devices and methods of using them
EP3471781A4 (en) Modulation of gys1 expression
EP3149049A4 (en) Modulation of cellular stress
EP3094323A4 (en) Methods and compositions for modulating hormone levels
HK1231649A1 (en) Signaling of modulation configuration
EP3137624A4 (en) Compositions and methods for modulating mtorc1
IL261089A (en) Methods of immunogenic modulation
EP3197558A4 (en) Compositions and methods for transient immune response modulation during vaccination
EP3220940A4 (en) Compositions and methods for modulating at2r activity
IL248728A0 (en) Compositions and means for induction of tumor immunity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171129

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20171123BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1235305

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20190116

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191203

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1235305

Country of ref document: HK